Title
Multifaceted Mechanism of Amicoumacin A Inhibition of Bacterial Translation
Date Issued
12 February 2021
Access level
open access
Resource Type
journal article
Author(s)
Maksimova E.M.
Vinogradova D.S.
Osterman I.A.
Kasatsky P.S.
Nikonov O.S.
Dontsova O.A.
Sergiev P.V.
Paleskava A.
Konevega A.L.
Publisher(s)
Frontiers Media S.A.
Abstract
Amicoumacin A (Ami) halts bacterial growth by inhibiting the ribosome during translation. The Ami binding site locates in the vicinity of the E-site codon of mRNA. However, Ami does not clash with mRNA, rather stabilizes it, which is relatively unusual and implies a unique way of translation inhibition. In this work, we performed a kinetic and thermodynamic investigation of Ami influence on the main steps of polypeptide synthesis. We show that Ami reduces the rate of the functional canonical 70S initiation complex (IC) formation by 30-fold. Additionally, our results indicate that Ami promotes the formation of erroneous 30S ICs; however, IF3 prevents them from progressing towards translation initiation. During early elongation steps, Ami does not compromise EF-Tu-dependent A-site binding or peptide bond formation. On the other hand, Ami reduces the rate of peptidyl-tRNA movement from the A to the P site and significantly decreases the amount of the ribosomes capable of polypeptide synthesis. Our data indicate that Ami progressively decreases the activity of translating ribosomes that may appear to be the main inhibitory mechanism of Ami. Indeed, the use of EF-G mutants that confer resistance to Ami (G542V, G581A, or ins544V) leads to a complete restoration of the ribosome functionality. It is possible that the changes in translocation induced by EF-G mutants compensate for the activity loss caused by Ami.
Volume
12
Language
English
OCDE Knowledge area
Bioquímica, Biología molecular
Scopus EID
2-s2.0-85101886894
Source
Frontiers in Microbiology
ISSN of the container
1664302X
Sponsor(s)
Funding text 1 We thank Kolyadenko IA for his help in data analysis and all members of the Dr. Andrey L. Konevega laboratory for scientific discussions, technical support and research performing. We thank Dr. Marina V. Rodnina for providing the plasmids encoding initiation and elongation factors. We thank Dr. Tatyana Efimenko and Dr. Olga V. Efremenkova (Gause Institute of New Antibiotics, Moscow, Russia) for their help with purification of Ami. Equipment for MST and DSF measurements (Monolith NT.115 and Prometheus NT.48) was provided by NanoTemper Technologies Rus, LLC (St. Petersburg, Russia). Funding. This work was supported by the Russian Science Foundation grant 17-14-01416 (to AK, pre-steady state kinetics of elongation reactions), experiments on various mRNAs were supported by Russian Foundation for Basic Research grants 17-00-00368 (to AK) and 17-00-00366 (to PS), mobility between the PM and AK labs was funded by the Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica grant 154-2017-Fondecyt. Funding text 2 This work was supported by the Russian Science Foundation grant 17-14-01416 (to AK, pre-steady state kinetics of elongation reactions), experiments on various mRNAs were supported by Russian Foundation for Basic Research grants 17-00-00368 (to
Sources of information: Directorio de Producción Científica Scopus